Compound triggers innate immunity against RNA viruses

Compound triggers innate immunity against RNA viruses
A recent research from UW Medicine and collaborators indicates that a drug-like molecule can trigger innate immunity through RIG-I (pathogen recognition receptor) and induce antiviral genes against a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza A, respiratory syncytial, Nipah, Lassa and Ebola. This research shows a promising evidence for creating a broad-spectrum antiviral.
How to cite this article:
Hameedunissa Begum Shariff. Compound triggers innate immunity against RNA viruses. BioLim O-Media. 10 April, 2017. 5(4).
Available from: http://archive.biolim.org/omedia/read/BOMA0225.